NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 37 filers reported holding NEUROCRINE BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $157,000 | +16.3% | 106,000 | 0.0% | 0.00% | – |
| Q2 2023 | $135,000 | +1587.5% | 106,000 | +1666.7% | 0.00% | – |
| Q1 2023 | $8,000 | -11.1% | 6,000 | 0.0% | 0.00% | – |
| Q4 2022 | $9,000 | 0.0% | 6,000 | -14.3% | 0.00% | – |
| Q3 2022 | $9,000 | +12.5% | 7,000 | +16.7% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 6,000 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | +14.3% | 6,000 | 0.0% | 0.00% | – |
| Q4 2021 | $7,000 | -12.5% | 6,000 | 0.0% | 0.00% | – |
| Q3 2021 | $8,000 | +60.0% | 6,000 | +50.0% | 0.00% | – |
| Q2 2021 | $5,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 4,000 | 0.0% | 0.00% | – |
| Q4 2020 | $6,000 | 0.0% | 4,000 | 0.0% | 0.00% | – |
| Q3 2020 | $6,000 | -14.3% | 4,000 | 0.0% | 0.00% | – |
| Q2 2020 | $7,000 | +40.0% | 4,000 | 0.0% | 0.00% | – |
| Q1 2020 | $5,000 | -16.7% | 4,000 | 0.0% | 0.00% | – |
| Q4 2019 | $6,000 | – | 4,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CSS LLC/IL | 15,659,000 | $23,207,687 | 1.52% |
| SONA ASSET MANAGEMENT (US) LLC | 17,500,000 | $26,317,952 | 1.09% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 26,765,000 | $40,113,099 | 0.86% |
| Warberg Asset Management LLC | 1,271,000 | $1,885,846 | 0.38% |
| SSI INVESTMENT MANAGEMENT LLC | 2,296,000 | $3,406,116 | 0.28% |
| Paloma Partners Management Co | 3,125,000 | $4,694,590 | 0.16% |
| FRANKLIN RESOURCES INC | 54,750,000 | $81,769,125 | 0.04% |
| Rock Springs Capital Management LP | 1,000,000 | $1,497,950 | 0.04% |
| LORD, ABBETT & CO. LLC | 4,666,000 | $6,922 | 0.03% |
| D. E. Shaw & Co., Inc. | 14,351,000 | $21,373,197 | 0.02% |